Literatur
-
1
Heusch G, Schulz R.
Pathophysiology of coronary microembolisation.
Heart.
2003;
89
981-982
-
2
Chen Z M, Pan H C, Chen Y P, Peto R, Collins R, Jiang L X, Xie J X, Liu L S. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group .
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Lancet.
2005;
366
1622-1632
-
3
Sabatine M S, Cannon C P, Gibson C M, Lopez-Sendon J L, Montalescot G, Theroux P, Claeys M J, Cools F, Hill K A, Skene A M, McCabe C H, Braunwald E. CLARITY-TIMI28Investigators .
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
N Engl J Med.
2005;
352
1179-1189
-
4
Piper H M, Meuter K, Schafer C.
Cellular mechanisms of ischemia-reperfusion injury.
Ann Thorac Surg.
2003;
75
S644-S648
-
5
Murry C E, Jennings R B, Reimer K A.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation.
1986;
74
1124-1136
-
6
Schulz R, Cohen M V, Behrends M, Downey J M, Heusch G.
Signal transduction of ischemic preconditioning.
Cardiovasc Res.
2001;
52
181-198
-
7
Heusch G.
Nitroglycerin and delayed preconditioning in humans. Yet another new mechanism for an old drug?.
Circulation.
2001;
103
2876-2878
-
8
Heusch G, Schulz R.
Remote Preconditioning.
J Mol Cell Cardiol.
2002;
34
1279-1281
-
9
Heusch G.
Postconditioning. Old wine in a new bottle?.
J Am Coll Cardiol.
2004;
44
1111-1112
-
10
Zhao Z-Q, Corvera J S, Halkos M E, Kerendi F, Wang N-P, Guyton R A, Vinten-Johansen J.
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
Am J Physiol Heart Circ Physiol.
2003;
285
H579-H588
Prof. Dr. med. Rainer Schulz
Institut für Pathophysiologie · Zentrum für Innere Medizin · Universitätsklinikum Essen
Hufelandstr. 55
45122 Essen
Email: rainer_schulz@uni-essen.de
